What is the current Tranexamic Acid Injection market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Tranexamic Acid Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Tranexamic Acid Injection market?

Increasing demand for hemostatic agents and rising cases of bleeding disorders drive the market.

What are the major challenges faced by the Tranexamic Acid Injection market?

Stringent regulatory approvals and competition from alternative treatments pose challenges.

Which regions are the leaders in the Tranexamic Acid Injection market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the Tranexamic Acid Injection market?

Pfizer, Johnson & Johnson, and Bayer are among the top companies in the market.

What are the future opportunities in the Tranexamic Acid Injection market?

Emerging economies and increasing use in surgical procedures offer future opportunities.

How does technology impact the Tranexamic Acid Injection market?

Advancements in injection technology and manufacturing processes improve product quality.

What is the regulatory landscape of the Tranexamic Acid Injection market?

Regulatory bodies like FDA and EMA ensure strict quality control and approval processes.

What is the future outlook of the Tranexamic Acid Injection market?

The market is expected to grow significantly due to increasing demand and advancements.

Tranexamic Acid Injection Growth Trends & Opportunity Analysis 2033

Tranexamic Acid Injection by Application (Hospital, Clinic, Other), by Types (5ml:0.5g, 5ml:0.25g), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Tranexamic Acid Injection Market Overview

The Tranexamic Acid Injection market refers to the global market for injectable tranexamic acid, a medication used to prevent and treat excessive blood loss. As a crucial component of hemostasis management, the Tranexamic Acid Injection market size is estimated to be approximately $723 million. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2026 to 2033. This industry expansion can be attributed to increasing demand for effective bleeding control measures in various medical settings. The scope of this market encompasses the development, production, and distribution of tranexamic acid injections, with key players competing to offer high-quality products that meet evolving consumer behavior and regulatory requirements.

Loading chart…

The growth of the Tranexamic Acid Injection market is influenced by key forces such as technology shifts, regulatory requirements, and competitive intensity. The largest region for this market is currently North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and improving medical infrastructure. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest developments and trends to capitalize on emerging opportunities and stay ahead of the competition.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fuzhou FU Yao Pharmaceutical Co.,Ltd.; Shanxi Pude Pharmaceutical CO.,Ltd.; Beijing Sunho Pharmaceutical Co.,Ltd.; Pfizer, Inc.; Hunan Dongting Pharmaceutical Co.,Ltd.; Guizhou Chitianhua CO.,LTD.; Shenyang Dong'ang Pharmaceutical Co.,Ltd.; Kaifeng Pharmaceutical (GROUP) Co.,Ltd.; Guangzhou Poinsettia Pharmaceutical Co.,Ltd.; Daiichi Sankyo; Sandoz; APOTEX; SteriMax Inc.; Alvogen; Auropharma Canada; Chongqing Lummy Pharmaceutical Co.,Ltd.; Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.; Criticine Care; GMT Pharma International; AdvaCare Pharma; Swisschem Healthcare; Iskon Remedies; SKG Internationals; Well Go Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Tranexamic Acid Injection market is poised for significant growth, driven by various factors. The market dynamics are influenced by a combination of growth drivers, restraints, opportunities, and challenges that shape the Tranexamic Acid Injection market size and growth forecast.

Growth Drivers2 items

Increasing demand for Tranexamic Acid Injection in the treatment of hemorrhagic shock and postpartum hemorrhage, driven by its effectiveness in reducing mortality rates and improving patient outcomes

Advancements in medical technology and pharmaceutical manufacturing, enabling the development of high-quality Tranexamic Acid Injection products with improved stability and shelf life

Restraints2 items

Stringent regulatory requirements and quality control measures that manufacturers must adhere to, increasing the complexity and cost of bringing Tranexamic Acid Injection products to market

Competition from alternative treatments and generic products, which can limit the market share and pricing power of Tranexamic Acid Injection manufacturers

Opportunities2 items

Growing demand for Tranexamic Acid Injection in emerging markets, driven by increasing access to healthcare and rising awareness of the importance of maternal health and trauma care

Opportunities for strategic partnerships and collaborations between manufacturers, distributors, and healthcare providers to improve the availability and affordability of Tranexamic Acid Injection products

Challenges2 items

Managing the supply chain and logistics of Tranexamic Acid Injection products, particularly in low-resource settings where infrastructure and transportation networks may be limited

Addressing the pricing pressure and reimbursement challenges faced by manufacturers, while ensuring that Tranexamic Acid Injection products remain accessible and affordable for patients and healthcare systems

Market Segmentation

Loading chart…

The Tranexamic Acid Injection market can be segmented based on its application, which includes treatment of heavy menstrual bleeding, treatment of hereditary angioedema, and treatment of bleeding after surgery or tooth removal. Each of these applications contributes to the overall Tranexamic Acid Injection market size, with the treatment of heavy menstrual bleeding being the largest contributor. Understanding the Tranexamic Acid Injection segmentation is crucial for market players to identify opportunities and develop targeted strategies.

In terms of types, the Tranexamic Acid Injection market can be categorized into injection solutions and lyophilized powders. Injection solutions are the most commonly used type of Tranexamic Acid Injection, accounting for the largest share of the market. Lyophilized powders, on the other hand, are gaining popularity due to their convenience and ease of use. The types of Tranexamic Acid Injection are an important aspect of market taxonomy, as they affect the overall market size and growth prospects.

Tranexamic Acid Injection Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

5ml:0.5g

5ml:0.25g

Regional Insights

Loading chart…

The Tranexamic Acid Injection market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the global market. This region is also anticipated to be the fastest-growing, driven by key factors such as increasing adoption of Tranexamic Acid Injection, government policies supporting the healthcare sector, and significant investments in healthcare infrastructure.

In North America, key drivers include a mature ecosystem, high demographics of patients requiring Tranexamic Acid Injection, and advanced infrastructure. Europe is driven by adoption of Tranexamic Acid Injection in hospitals, policies supporting the use of generic drugs, and a strong ecosystem. Latin America and Middle East & Africa are expected to experience steady growth, driven by increasing adoption, improving infrastructure, and government investments in healthcare.

The regional forecast indicates that Asia Pacific will continue to dominate the Tranexamic Acid Injection market, with a growth rate driven by the increasing demand for Tranexamic Acid Injection and the expanding ecosystem. The Tranexamic Acid Injection market is expected to experience significant growth in all regions, driven by key factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity.

Competitive Landscape

The Tranexamic Acid Injection market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Tranexamic Acid Injection competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios, channel strength, and cost advantages. Key players are driving growth through strategic partnerships, expansions, and research and development.

Companies in the market are adopting various strategies to stay competitive, including mergers and acquisitions, partnerships, product launches, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To differentiate themselves, companies are focusing on technology, service models, and customization. The following companies are examples of this strategic focus:

Fuzhou FU Yao: regional expansion

Shanxi Pude: vertical integration

Pfizer: premium pricing

Daiichi Sankyo: innovation pipeline

Sandoz: local manufacturing

Auropharma: OEM tie-ups

Key Tranexamic Acid Injection Companies24 items

Fuzhou FU Yao Pharmaceutical Co.,Ltd.

Shanxi Pude Pharmaceutical CO.,Ltd.

Beijing Sunho Pharmaceutical Co.,Ltd.

Pfizer, Inc.

Hunan Dongting Pharmaceutical Co.,Ltd.

Guizhou Chitianhua CO.,LTD.

Shenyang Dong'ang Pharmaceutical Co.,Ltd.

Kaifeng Pharmaceutical (GROUP) Co.,Ltd.

Guangzhou Poinsettia Pharmaceutical Co.,Ltd.

Daiichi Sankyo

Sandoz

APOTEX

SteriMax Inc.

Alvogen

Auropharma Canada

Chongqing Lummy Pharmaceutical Co.,Ltd.

Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.

Criticine Care

GMT Pharma International

AdvaCare Pharma

Swisschem Healthcare

Iskon Remedies

SKG Internationals

Well Go Pharma

Market Ecosystem

The Tranexamic Acid Injection ecosystem encompasses a complex network of participants, spanning from upstream raw material suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value created and captured at each stage through the interactions of various participants, including technology providers, integrators, channels, and end users. Understanding the Tranexamic Acid Injection ecosystem through a value chain analysis is crucial for identifying key drivers of growth, challenges, and opportunities.

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Tranexamic Acid Injection products

Technology providers — develop manufacturing technologies and equipment

Distributors / channel partners — facilitate product distribution to healthcare facilities

Service providers / after-sales — offer support and maintenance services for equipment

End users / buyers — healthcare professionals and institutions administering the injections

Regulators/standards bodies — establish and enforce quality and safety standards

The flow of value within the Tranexamic Acid Injection ecosystem is influenced by control points such as regulatory approvals and standards, which can create bottlenecks and impact adoption rates. Dependency risks, including input constraints and approvals, can also affect the ecosystem's efficiency. Furthermore, the ecosystem's structure and dynamics can vary by region due to differences in healthcare infrastructure, regulatory frameworks, and market demands, leading to distinct challenges and opportunities in different geographic areas.

Recent Industry Insights

The Tranexamic Acid Injection industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on expanding distribution networks and enhancing product availability. Notably, several mergers and acquisitions have taken place, leading to market consolidation and increased competition. Furthermore, innovative product launches have improved treatment outcomes, driving growth in the Tranexamic Acid Injection market.

Additionally, regulatory changes have paved the way for increased adoption of Tranexamic Acid Injection, particularly in emerging markets. A shift in consumer trends towards minimally invasive procedures has also contributed to the market's growth. Funding rounds and expansions have enabled companies to invest in research and development, leading to the introduction of new technologies and treatment options. These developments are expected to shape the future of the Tranexamic Acid Injection industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Tranexamic Acid Injection market outlook. The market attractiveness is moderate due to the increasing demand for effective bleeding control treatments. The competitive intensity is high, with several key players competing for market share. The long-term outlook is positive, driven by the growing need for antifibrinolytic agents in various medical applications.

The innovation landscape is evolving, with ongoing research and development focused on improving the efficacy and safety of Tranexamic Acid Injection products. The demand-supply balance is relatively stable, although fluctuations may occur due to factors such as raw material availability and regulatory changes. Key risk factors include market volatility and supply chain disruptions, which can impact the overall growth of the market.

12 items

1. Executive Summary

2. Tranexamic Acid Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Tranexamic Acid Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Tranexamic Acid Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Tranexamic Acid Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Tranexamic Acid Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Tranexamic Acid Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Tranexamic Acid Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Tranexamic Acid Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Tranexamic Acid Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Tranexamic Acid Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Tranexamic Acid Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Tranexamic Acid Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Tranexamic Acid Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Tranexamic Acid Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Tranexamic Acid Injection Market Competition by Key Manufacturers

9.1. Global Tranexamic Acid Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Tranexamic Acid Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Fuzhou FU Yao Pharmaceutical Co.,Ltd.

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Shanxi Pude Pharmaceutical CO.,Ltd.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Beijing Sunho Pharmaceutical Co.,Ltd.

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Pfizer, Inc.

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Hunan Dongting Pharmaceutical Co.,Ltd.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Guizhou Chitianhua CO.,LTD.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Shenyang Dong'ang Pharmaceutical Co.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Kaifeng Pharmaceutical (GROUP) Co.,Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Guangzhou Poinsettia Pharmaceutical Co.,Ltd.

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Daiichi Sankyo

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Sandoz

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. APOTEX

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. SteriMax Inc.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Alvogen

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Auropharma Canada

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Chongqing Lummy Pharmaceutical Co.,Ltd.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Criticine Care

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. GMT Pharma International

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. AdvaCare Pharma

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Swisschem Healthcare

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Iskon Remedies

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. SKG Internationals

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Well Go Pharma

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Tranexamic Acid Injection Market

Figure 4: Global Tranexamic Acid Injection Market: Drivers

Figure 5: Global Tranexamic Acid Injection Market: Challenges

Figure 6: Global Tranexamic Acid Injection Market: Trends

Figure 7: Global Tranexamic Acid Injection Market: Opportunity

Figure 8: Global Tranexamic Acid Injection Market: Restraint

Figure 9: Global Tranexamic Acid Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Tranexamic Acid Injection Market Value (USD Million) By Region

Figure 19: Global Tranexamic Acid Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Tranexamic Acid Injection Market Value (USD Million) By Region

Figure 27: Global Tranexamic Acid Injection Market Share (%) By: Regions (2032)

Figure 28: Global Tranexamic Acid Injection Market Volume (K) By Region

Figure 29: Global Tranexamic Acid Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Tranexamic Acid Injection Market Value (USD Million) By Region

Figure 37: Global Tranexamic Acid Injection Market Share (%) By: Regions (2032)

Figure 38: Global Tranexamic Acid Injection Market Volume (K) By Region

Figure 39: Global Tranexamic Acid Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

143 items

Table 1: Market Segmentation Analysis

Table 2: Global Tranexamic Acid Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Tranexamic Acid Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Tranexamic Acid Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Tranexamic Acid Injection Market Value (USD Million) By Region

Table 14: Global Tranexamic Acid Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Tranexamic Acid Injection Market Volume (K) By Region

Table 31: Global Tranexamic Acid Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Tranexamic Acid Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Tranexamic Acid Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Tranexamic Acid Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Fuzhou FU Yao Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 52: Fuzhou FU Yao Pharmaceutical Co.,Ltd.. Products Portfolio

Table 53: Shanxi Pude Pharmaceutical CO.,Ltd. Basic Information And Sales Area

Table 54: Shanxi Pude Pharmaceutical CO.,Ltd.. Products Portfolio

Table 55: Beijing Sunho Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 56: Beijing Sunho Pharmaceutical Co.,Ltd.. Products Portfolio

Table 57: Pfizer, Inc. Basic Information And Sales Area

Table 58: Pfizer, Inc.. Products Portfolio

Table 59: Hunan Dongting Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 60: Hunan Dongting Pharmaceutical Co.,Ltd.. Products Portfolio

Table 61: Guizhou Chitianhua CO.,LTD. Basic Information And Sales Area

Table 62: Guizhou Chitianhua CO.,LTD.. Products Portfolio

Table 63: Shenyang Dong'ang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 64: Shenyang Dong'ang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 65: Kaifeng Pharmaceutical (GROUP) Co.,Ltd. Basic Information And Sales Area

Table 66: Kaifeng Pharmaceutical (GROUP) Co.,Ltd.. Products Portfolio

Table 67: Guangzhou Poinsettia Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 68: Guangzhou Poinsettia Pharmaceutical Co.,Ltd.. Products Portfolio

Table 69: Daiichi Sankyo Basic Information And Sales Area

Table 70: Daiichi Sankyo. Products Portfolio

Table 71: Sandoz Basic Information And Sales Area

Table 72: Sandoz. Products Portfolio

Table 73: APOTEX Basic Information And Sales Area

Table 74: APOTEX. Products Portfolio

Table 75: SteriMax Inc. Basic Information And Sales Area

Table 76: SteriMax Inc.. Products Portfolio

Table 77: Alvogen Basic Information And Sales Area

Table 78: Alvogen. Products Portfolio

Table 79: Auropharma Canada Basic Information And Sales Area

Table 80: Auropharma Canada. Products Portfolio

Table 81: Chongqing Lummy Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 82: Chongqing Lummy Pharmaceutical Co.,Ltd.. Products Portfolio

Table 83: Guangzhou Baiyunshan Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 84: Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.. Products Portfolio

Table 85: Criticine Care Basic Information And Sales Area

Table 86: Criticine Care. Products Portfolio

Table 87: GMT Pharma International Basic Information And Sales Area

Table 88: GMT Pharma International. Products Portfolio

Table 89: AdvaCare Pharma Basic Information And Sales Area

Table 90: AdvaCare Pharma. Products Portfolio

Table 91: Swisschem Healthcare Basic Information And Sales Area

Table 92: Swisschem Healthcare. Products Portfolio

Table 93: Iskon Remedies Basic Information And Sales Area

Table 94: Iskon Remedies. Products Portfolio

Table 95: SKG Internationals Basic Information And Sales Area

Table 96: SKG Internationals. Products Portfolio

Table 97: Well Go Pharma Basic Information And Sales Area

Table 98: Well Go Pharma. Products Portfolio

Table 99: Global Market Value (USD Million) (2025-2032) By Application

Table 100: Global Market Share (%) By Application (2032)

Table 101: Global Market Value (USD Million) (2025-2032) By Types

Table 102: Global Market Share (%) By Types (2032)

Table 103: Global Market Volume (K) (2025-2032) By Application

Table 104: Global Market Share (%) By Application (2032)

Table 105: Global Market Volume (K) (2025-2032) By Types

Table 106: Global Market Share (%) By Types (2032)

Table 107: Global Tranexamic Acid Injection Market Value (USD Million) By Region

Table 108: Global Tranexamic Acid Injection Market Share (%) By Region (2025-2032)

Table 109: North America Market Value (USD Million) (2025-2032) By Country

Table 110: North America Market Value (USD Million) (2025-2032) By Application

Table 111: North America Market Value (USD Million) (2025-2032) By Types

Table 112: Europe Market Value (USD Million) (2025-2032) By Country

Table 113: Europe Market Value (USD Million) (2025-2032) By Application

Table 114: Europe Market Value (USD Million) (2025-2032) By Types

Table 115: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 116: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 117: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 118: South America Market Value (USD Million) (2025-2032) By Country

Table 119: South America Market Value (USD Million) (2025-2032) By Application

Table 120: South America Market Value (USD Million) (2025-2032) By Types

Table 121: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 122: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 123: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 124: Global Tranexamic Acid Injection Market Volume (K) By Region

Table 125: Global Tranexamic Acid Injection Market Share (%) By Region (2025-2032)

Table 126: North America Market Volume (K) (2025-2032) By Country

Table 127: North America Market Volume (K) (2025-2032) By Application

Table 128: North America Market Volume (K) (2025-2032) By Types

Table 129: Europe Market Volume (K) (2025-2032) By Country

Table 130: Europe Market Volume (K) (2025-2032) By Application

Table 131: Europe Market Volume (K) (2025-2032) By Types

Table 132: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 133: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 134: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 135: South America Market Volume (K) (2025-2032) By Country

Table 136: South America Market Volume (K) (2025-2032) By Application

Table 137: South America Market Volume (K) (2025-2032) By Types

Table 138: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 139: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 140: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 141: Research Programs/Design For This Report

Table 142: Key Data Information From Secondary Sources

Table 143: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Tranexamic Acid Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fuzhou FU Yao Pharmaceutical Co.,Ltd.; Shanxi Pude Pharmaceutical CO.,Ltd.; Beijing Sunho Pharmaceutical Co.,Ltd.; Pfizer, Inc.; Hunan Dongting Pharmaceutical Co.,Ltd.; Guizhou Chitianhua CO.,LTD.; Shenyang Dong'ang Pharmaceutical Co.,Ltd.; Kaifeng Pharmaceutical (GROUP) Co.,Ltd.; Guangzhou Poinsettia Pharmaceutical Co.,Ltd.; Daiichi Sankyo; Sandoz; APOTEX; SteriMax Inc.; Alvogen; Auropharma Canada; Chongqing Lummy Pharmaceutical Co.,Ltd.; Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.; Criticine Care; GMT Pharma International; AdvaCare Pharma; Swisschem Healthcare; Iskon Remedies; SKG Internationals; Well Go Pharma
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in medical technology and pharmaceutical manufacturing, enabling the development of high-quality Tranexamic Acid Injection products with improved stability and shelf life

Restraints2 items

Stringent regulatory requirements and quality control measures that manufacturers must adhere to, increasing the complexity and cost of bringing Tranexamic Acid Injection products to market

Competition from alternative treatments and generic products, which can limit the market share and pricing power of Tranexamic Acid Injection manufacturers

Opportunities2 items

Growing demand for Tranexamic Acid Injection in emerging markets, driven by increasing access to healthcare and rising awareness of the importance of maternal health and trauma care

Challenges2 items

Managing the supply chain and logistics of Tranexamic Acid Injection products, particularly in low-resource settings where infrastructure and transportation networks may be limited

Market Segmentation

Loading chart…

Tranexamic Acid Injection Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

5ml:0.5g

5ml:0.25g

Regional Insights

Loading chart…

Competitive Landscape

Fuzhou FU Yao: regional expansion

Shanxi Pude: vertical integration

Pfizer: premium pricing

Daiichi Sankyo: innovation pipeline

Sandoz: local manufacturing

Auropharma: OEM tie-ups

Key Tranexamic Acid Injection Companies24 items

Fuzhou FU Yao Pharmaceutical Co.,Ltd.

Shanxi Pude Pharmaceutical CO.,Ltd.

Beijing Sunho Pharmaceutical Co.,Ltd.

Pfizer, Inc.

Hunan Dongting Pharmaceutical Co.,Ltd.

Guizhou Chitianhua CO.,LTD.

Shenyang Dong'ang Pharmaceutical Co.,Ltd.

Kaifeng Pharmaceutical (GROUP) Co.,Ltd.

Guangzhou Poinsettia Pharmaceutical Co.,Ltd.

Daiichi Sankyo

Sandoz

APOTEX

SteriMax Inc.

Alvogen

Auropharma Canada

Chongqing Lummy Pharmaceutical Co.,Ltd.

Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.

Criticine Care

GMT Pharma International

AdvaCare Pharma

Swisschem Healthcare

Iskon Remedies

SKG Internationals

Well Go Pharma

Market Ecosystem

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Tranexamic Acid Injection products

Technology providers — develop manufacturing technologies and equipment

Distributors / channel partners — facilitate product distribution to healthcare facilities

Service providers / after-sales — offer support and maintenance services for equipment

End users / buyers — healthcare professionals and institutions administering the injections

Regulators/standards bodies — establish and enforce quality and safety standards

Recent Industry Insights

Analyst Overview

Table of Contents